Toronto partner and Leader of Fasken’s Health Law group, Laurie Turner, and Toronto partner in the firm's Business Law group, Claire Gowdy, discuss healthcare M&A trends in Canada in an article published by Lexpert.
Turner highlighted the unique regulatory challenges that set healthcare transactions apart from deals in many other industries.
“These transactions require structures that comply with healthcare regulations while still allowing investors to participate in the economics of the business,” said Turner.
Gowdy discussed the growing role of artificial intelligence in healthcare M&A across a range of subsectors, noting that buyers are increasingly assessing whether a company’s use of AI enhances its growth potential through digital transformation and operational efficiencies.
“We’re not seeing companies acquired simply because they have AI,” said Gowdy. “It’s one factor that’s considered in evaluating the overall strength and future potential of the business.”
